Evidence map›Paper›PMID 30811499›Full record

ArticlePLoS pathogens2019

Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection.

Marion Pardons, Amy E Baxter, Marta Massanella, Amélie Pagliuzza, Rémi Fromentin, Caroline Dufour, Louise Leyre, Jean-Pierre Routy, Daniel E Kaufmann, Nicolas Chomont

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 165 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
165citing papers in PubMed, 1 pooled it
18.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

165 citing papers in PubMed, 1 synthesis or guideline pooled it, 234 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The immunophenotype and proviral landscape of HIV-infected CD4 T cells during antiretroviral therapy.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. HCV-specific CD4EBioMedicine · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. HIV reservoirs in lymphomagenesis: hidden driver in the era of viral suppression?Microbiology and molecular biology reviews : MMBR · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Marion PardonsDepartment of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, Quebec, Canada.
Amy E BaxterDepartment of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, Quebec, Canada.ORCID 0000-0002-1555-0713
Marta MassanellaDepartment of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, Quebec, Canada.ORCID 0000-0002-3326-151X
Amélie PagliuzzaCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Rémi FromentinCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.ORCID 0000-0002-8153-1799
Caroline DufourDepartment of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, Quebec, Canada.
Louise LeyreDepartment of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, Quebec, Canada.ORCID 0000-0002-7890-702X
Jean-Pierre RoutyDivision of Hematology & Chronic Viral Illness Service, McGill University Heath Centre, Montreal, Quebec, Canada.ORCID 0000-0001-9897-7589
Daniel E KaufmannCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.ORCID 0000-0003-4467-136X
Nicolas ChomontDepartment of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, Quebec, Canada.ORCID 0000-0001-9747-5018
Université de Montréal · CACentre Hospitalier de l’Université de Montréal · CAMcGill University Health Centre · CA

Funding

Delaney AIDS Research Enterprise to Cure HIVUM1AI126611 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEEKS, STEVEN GRANT, PICKER, LOUIS J. · 2016 to 2020
$27.9M
Canadian Institutes for Health Research 364408Canadian Institutes for Health Research 377124Canadian Institutes for Health Research 385806NIAID NIH HHS UM1 AI126611
6 · The paper itself

Abstract

The phenotypic characterization of the cells in which HIV persists during antiretroviral therapy (ART) remains technically challenging. We developed a simple flow cytometry-based assay to quantify and characterize infected cells producing HIV proteins during untreated and treated HIV infection. By combining two antibodies targeting the HIV capsid in a standard intracellular staining protocol, we demonstrate that p24-producing cells can be detected with high specificity and sensitivity in the blood from people living with HIV. In untreated individuals, the frequency of productively infected cells strongly correlated with plasma viral load. Infected cells preferentially displayed a transitional memory phenotype and were enriched in Th17, peripheral Tfh and regulatory T cells subsets. These cells also preferentially expressed activation markers (CD25, HLA-DR, Ki67), immune checkpoint molecules (PD-1, LAG-3, TIGIT, Tim-3) as well as the integrins α4β7 and α4β1. In virally suppressed individuals on ART, p24-producing cells were only detected upon stimulation (median frequency of 4.3 p24+ cells/106 cells). These measures correlated with other assays assessing the size of the persistent reservoir including total and integrated HIV DNA, Tat/rev Induced Limiting Dilution Assay (TILDA) and quantitative viral outgrowth assay (QVOA). In ART-suppressed individuals, p24-producing cells preferentially displayed a transitional and effector memory phenotype, and expressed immune checkpoint molecules (PD-1, TIGIT) as well as the integrin α4β1. Remarkably, α4β1 was expressed by more than 70% of infected cells both in untreated and ART-suppressed individuals. Altogether, these results highlight a broad diversity in the phenotypes of HIV-infected cells in treated and untreated infection and suggest that strategies targeting multiple and phenotypically distinct cellular reservoirs will be needed to exert a significant impact on the size of the reservoir.

Indexed as

AdultAnti-Retroviral AgentsCD4-Positive T-LymphocytesDisease ReservoirsFemaleFlow CytometryHIVHIV-1HIV Core Protein p24HIV InfectionsHumansIntegrin alpha4beta1MaleMiddle AgedPhenotypeRNA, ViralAnti-Retroviral AgentsHIV Core Protein p24Integrin alpha4beta1RNA, Viral

Identifiers

PMID30811499
PMCPMC6411230
OpenAlexW2916314751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.